BioLingus is a biotechnology company that develops oral and mucosal delivery of peptides and proteins. It offers novel bio-mimetic materials for drug delivery, insulins, liraglutide, exenatide, semaglutide, sublingual dual incretin inhibitor, etc. The company focuses on the treatment of diabetes, obesity, and inflammatory diseases.